Insider · CIK 0001278219

Zoth Lota S.

Reports to the SEC for 11 companies · SAINT-LAURENT

sec.gov

Transactions

Companies

Filings

CIK

0001278219

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,000
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+41.8K sh	—	—	41,800
2026-05-20	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+34.2K sh	—	—	34,200
2026-04-28	FFINFIRST FINANCIAL BANKSHARES INCA Award	Director	AAward	+2,142 sh	—	—	2,142
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.4K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.2K sh	—	—	0
2025-10-30	ETNB89bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2025-06-16	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2025-05-21	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,167 sh	—	—	8,726
2025-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,167 sh	—	—	0
2025-02-03	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+56.4K sh	—	—	56,400
2024-12-12	LUMOS PHARMA, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,187 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,345 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,328 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,684 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,431 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,910 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,777 sh	—	—	0
2024-12-12	LUMOS PHARMA, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,324 sh	—	—	0
2024-06-15	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2024-06-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,328 sh	—	—	3,328
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+2,917 sh	—	—	2,917
2024-05-21	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+2,167 sh	—	—	2,167
2024-05-15	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,166 sh	—	—	6,559
2024-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−2,166 sh	—	—	0
2024-03-21	ENGNenGene Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-02-01	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,150
2023-06-05	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−5,700 sh	$0.56	−$3,192	52,716
2023-05-16	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+19K sh	—	—	58,416
2023-05-16	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−19K sh	—	—	0
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2023-05-15	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+26K sh	—	—	26,000
2023-05-10	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,345 sh	—	—	3,345
2023-02-09	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,400
2022-12-21	ZYMEZymeworks Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-16	ETNB89bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-16	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−3,600 sh	$1.98	−$7,128	39,416
2022-05-16	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitA Award	Director	AAward	+19K sh	—	—	19,000
2022-05-16	INOINOVIO PHARMACEUTICALS, INC. · Common Stock OptionsA Award	Director	AAward	+28K sh	—	—	28,000
2022-05-13	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+18K sh	—	—	43,016
2022-05-13	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−18K sh	—	—	0
2022-05-05	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+3,431 sh	—	—	3,431
2022-01-05	INOINOVIO PHARMACEUTICALS, INC.S Sale	Director	SSale	−961 sh	$5.01	−$4,814.61	25,016
2022-01-03	INOINOVIO PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,090 sh	—	—	25,977
2022-01-03	INOINOVIO PHARMACEUTICALS, INC. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−4,090 sh	—	—	0
2021-05-20	LUMOS PHARMA, INC.A Award	Director	AAward	+367 sh	—	—	2,187
2021-05-20	LUMOS PHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+2,910 sh	—	—	2,910

Recent filings

Accepted (ET)
Jun 174
Zoth Lota S.0000929638-26-002256
SEC(opens sec.gov)
May 214
Zoth Lota S.0001278219-26-000001
SEC(opens sec.gov)
May 54
Zoth Lota S.0001193125-26-206910
SEC(opens sec.gov)
Oct 304
Zoth Lota S.0001193125-25-259046
SEC(opens sec.gov)
Jun 164
Zoth Lota S.0000929638-25-002253
SEC(opens sec.gov)
May 214
Zoth Lota S.0001055726-25-000040
SEC(opens sec.gov)
Feb 54
Zoth Lota S.0000950170-25-014435
SEC(opens sec.gov)
Dec 134
Zoth Lota S.0001126234-24-000121
SEC(opens sec.gov)

Companies

Address

C/O 4868 RUE LEVY, SUITE 220

SAINT-LAURENT, H4R 2P1